1
|
Anand A, Malik TH, Dunson J, McDonald MF, Christmann CR, Galvan NTN, O'Mahony C, Goss JA, Srivaths PR, Brewer ED, Rana A. Factors associated with long-term graft survival in pediatric kidney transplant recipients. Pediatr Transplant 2021; 25:e13999. [PMID: 33704871 DOI: 10.1111/petr.13999] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/29/2020] [Revised: 12/22/2020] [Accepted: 02/24/2021] [Indexed: 12/13/2022]
Abstract
Pediatric kidney transplant recipients generally have good outcomes post-transplantation. However, the younger age and longer life span after transplantation in the pediatric population make understanding the multifactorial nature of long-term graft survival critical. This investigation analyzes factors associated with 10-year survival to identify areas for improvement in patient care. Kaplan-Meier with log-rank test and univariable and multivariable logistic regression methods were used to retrospectively analyze 7785 kidney transplant recipients under the age of 18 years from January 1, 1998, until March 9, 2008, using United Network for Organ Sharing (UNOS) data. Our end-point was death-censored 10-year graft survival after excluding recipients whose grafts failed within one year of transplant. Recipients aged 5-18 years had lower 10-year graft survival, which worsened as age increased: 5-9 years (OR: 0.66; CI: 0.52-0.83), 10-14 years (OR: 0.43; CI: 0.33-0.55), and 15-18 years (OR: 0.34; CI: 0.26-0.44). Recipient African American ethnicity (OR: 0.67; CI: 0.58-0.78) and Hispanic donor ethnicity (OR: 0.82; CI: 0.72-0.94) had worse outcomes than other donor and recipient ethnicities, as did patients on dialysis at the time of transplant (OR: 0.82; CI: 0.73-0.91). Recipient private insurance status (OR: 1.35; CI: 1.22-1.50) was protective for 10-year graft survival. By establishing the role of age, race, and insurance status on long-term graft survival, we hope to guide clinicians in identifying patients at high risk for graft failure. This study highlights the need for increased allocation of resources and medical care to reduce the disparity in outcomes for certain patient populations.
Collapse
Affiliation(s)
- Adrish Anand
- Department of Student Affairs, Baylor College of Medicine, Houston, Texas, USA
| | - Tahir H Malik
- Department of Student Affairs, Baylor College of Medicine, Houston, Texas, USA
| | - Jordan Dunson
- Department of Student Affairs, Baylor College of Medicine, Houston, Texas, USA
| | - Malcolm F McDonald
- Department of Student Affairs, Baylor College of Medicine, Houston, Texas, USA
| | | | - Nhu Thao Nguyen Galvan
- Division of Abdominal Transplant, Michael E DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas, USA
| | - Christine O'Mahony
- Division of Abdominal Transplant, Michael E DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas, USA
| | - John A Goss
- Division of Abdominal Transplant, Michael E DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas, USA
| | - Poyyapakkam R Srivaths
- Renal Section, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA
| | - Eileen D Brewer
- Renal Section, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA
| | - Abbas Rana
- Division of Abdominal Transplant, Michael E DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas, USA
| |
Collapse
|
2
|
Zolota A, Solonaki F, Katsanos G, Papagiannis A, Salveridis N, Tranta A, Deligiannidis T, Karakasi KE, Nikolaidou C, Papadimitriou C, Fouza A, Papanikolaou V, Miserlis G, Antoniadis N, Fouzas I. Long-Term (≥25 Years) Kidney Allograft Survivors: Retrospective Analysis at a Single Center. Transplant Proc 2020; 52:3044-3050. [PMID: 32571706 DOI: 10.1016/j.transproceed.2020.02.152] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/02/2019] [Revised: 01/14/2020] [Accepted: 02/05/2020] [Indexed: 11/29/2022]
Abstract
INTRODUCTION Despite great improvements in the short-term patient and kidney graft survival, the long-term morbidity and mortality in kidney transplant recipients still remains a significant problem. The aim of the study was to evaluate the impact of both donor and transplant recipient factors, as well as renal function indices on the very long-term (>25 years) kidney allograft survival. MATERIAL AND METHODS Retrospective analysis was performed on the data of 41 kidney transplant recipients (KTR), group A: follow-up = 25 years, 20 KTR, 10 male, mean age (mean [M] ± standard deviation [SD]): 34.6 ± 12.6 years, 14 living donors (LD), 6 cadaveric donors (CD); group B: follow-up > 25 years, 21 KTR, 16 male, mean age (M ± SD): 30.86 ± 12.37 years, 14 LD, 7 CD). Kidney graft origin, post-kidney transplantation diabetes mellitus, HLA compatibility, delayed graft function, and acute rejection episodes were also analyzed retrospectively. Statistical analysis with Mann-Whitney test and Kaplan-Meier survival analysis was performed (SPSS 20.0 for Windows). RESULTS The mean age of CDs was lower than that of LDs: CD mean age (M ± SD): 23.84 ± 16.26 years vs LD mean age: 52.75 ± 12.42 years (P < .001). Cadaveric kidney graft was associated with better renal allograft function 10, 15, and 25 years post kidney transplant. None of the other factors analyzed reached statistical significance between the 2 groups. CONCLUSION The age of the donor and the kidney graft origin are important co-factors of the very long-term kidney allograft survival.
Collapse
Affiliation(s)
- A Zolota
- Organ Transplantation Unit, Aristotle University of Thessaloniki, Hippokration General Hospital, Thessaloniki, Greece.
| | - F Solonaki
- Organ Transplantation Unit, Aristotle University of Thessaloniki, Hippokration General Hospital, Thessaloniki, Greece
| | - G Katsanos
- Organ Transplantation Unit, Aristotle University of Thessaloniki, Hippokration General Hospital, Thessaloniki, Greece
| | - A Papagiannis
- Organ Transplantation Unit, Aristotle University of Thessaloniki, Hippokration General Hospital, Thessaloniki, Greece
| | - N Salveridis
- Organ Transplantation Unit, Aristotle University of Thessaloniki, Hippokration General Hospital, Thessaloniki, Greece
| | - A Tranta
- Organ Transplantation Unit, Aristotle University of Thessaloniki, Hippokration General Hospital, Thessaloniki, Greece
| | - T Deligiannidis
- Organ Transplantation Unit, Aristotle University of Thessaloniki, Hippokration General Hospital, Thessaloniki, Greece
| | - K E Karakasi
- Organ Transplantation Unit, Aristotle University of Thessaloniki, Hippokration General Hospital, Thessaloniki, Greece
| | - C Nikolaidou
- Organ Transplantation Unit, Aristotle University of Thessaloniki, Hippokration General Hospital, Thessaloniki, Greece
| | - C Papadimitriou
- Organ Transplantation Unit, Aristotle University of Thessaloniki, Hippokration General Hospital, Thessaloniki, Greece
| | - A Fouza
- Organ Transplantation Unit, Aristotle University of Thessaloniki, Hippokration General Hospital, Thessaloniki, Greece
| | - V Papanikolaou
- Organ Transplantation Unit, Aristotle University of Thessaloniki, Hippokration General Hospital, Thessaloniki, Greece
| | - G Miserlis
- Organ Transplantation Unit, Aristotle University of Thessaloniki, Hippokration General Hospital, Thessaloniki, Greece
| | - N Antoniadis
- Organ Transplantation Unit, Aristotle University of Thessaloniki, Hippokration General Hospital, Thessaloniki, Greece
| | - I Fouzas
- Organ Transplantation Unit, Aristotle University of Thessaloniki, Hippokration General Hospital, Thessaloniki, Greece
| |
Collapse
|
3
|
Tanrikulu Y, Sahin M, Kismet K, Kilicoglu SS, Devrim E, Tanrikulu CS, Erdemli E, Erel S, Bayraktar K, Akkus MA. The protective effect of diosmin on hepatic ischemia reperfusion injury: an experimental study. Bosn J Basic Med Sci 2014; 13:218-24. [PMID: 24289756 DOI: 10.17305/bjbms.2013.2305] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023] Open
Abstract
Liver ischemia reperfusion injury (IRI) is an important pathologic process leading to bodily systemic effects and liver injury. Our study aimed to investigate the protective effects of diosmin, a phlebotrophic drug with antioxidant and anti-inflammatory effects, in a liver IRI model. Forty rats were divided into 4 groups. Sham group, control group (ischemia-reperfusion), intraoperative treatment group, and preoperative treatment group. Ischemia reperfusion model was formed by clamping hepatic pedicle for a 60 minute of ischemia followed by liver reperfusion for another 90 minutes. Superoxide dismutase (SOD) and catalase (CAT) were measured as antioaxidant enzymes in the liver tissues, and malondialdehyde (MDA) as oxidative stress marker, xanthine oxidase (XO) as an oxidant enzyme and glutathione peroxidase (GSH-Px) as antioaxidant enzyme were measured in the liver tissues and the plasma samples. Hepatic function tests were lower in treatment groups than control group (p<0.001 for ALT and AST). Plasma XO and MDA levels were lower in treatment groups than control group, but plasma GSH-Px levels were higher (p<0.05 for all). Tissue MDA levels were lower in treatment groups than control group, but tissue GSH-Px, SOD, CAT and XO levels were higher (p<0.05 for MDA and p<0.001 for others). Samples in control group histopathologically showed morphologic abnormalities specific to ischemia reperfusion. It has been found that both preoperative and intraoperative diosmin treatment decreases cellular damage and protects cells from toxic effects in liver IRI. As a conclusion, diosmin may be used as a protective agent against IRI in elective and emergent liver surgical operations.
Collapse
Affiliation(s)
- Yusuf Tanrikulu
- Department of General Surgery, Ankara Training and Research Hospital, Ministry of Health, Ulucanlar Street, 06340, Ankara, Turkey
| | | | | | | | | | | | | | | | | | | |
Collapse
|
4
|
Pintar T, Alessiani M, Pleskovič A, Pleskovič A, Zorc-Pleskovič R, Milutinović A. Skin and kidney histological changes in graft-versus-host disease (GVHD) after kidney transplantation. Bosn J Basic Med Sci 2011; 11:119-23. [PMID: 21619560 DOI: 10.17305/bjbms.2011.2594] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/02/2023] Open
Abstract
Kidney transplantation (Ktx) is generally performed during end stage renal disease due to a loss of the kidneys' ability to filter wastes from the circulatory system. Acute graft-versus-host disease (GVHD) after Ktx is a life-threatening complication that progresses to organ failure, systemic complications, and death. The current study evaluated the significance of histologic findings of GVHD as obtained from skin biopsies following Ktx in swine. A swine model of Ktx with tacrolimus-based immunosuppression was used to assess possible correlations between acute-graft-cellular rejection and skin histological findings for prediction of GVHD. Animals were divided into a Ktx treatment group or a control group with no Ktx and skin and kidney biopsies were histologically assessed at postoperative days 0, 15, 30, 45 and 60. Skin samples were analyzed and classified from grade 1 to 4 of skin GVHD and the major histopathological changes of kidney acute cellular rejection were described using Banff's score system. We observed a significant linear correlation between the histological grading values of skin biopsy changes and the histological grading values of kidney biopsies (Kendall's tau_b=0.993) in the Ktx experimental group. No histological changes were observed in controls. Our findings demonstrate the diagnostic value of staging skin GVHD after Ktx and suggest it's future utility for monitoring long term Ktx-induced changes.
Collapse
Affiliation(s)
- Tadeja Pintar
- Abdominal Surgery Department, University Medical Centre of Ljubljana, Slovenia
| | | | | | | | | | | |
Collapse
|